Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome

NCT01625455 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

7

Enrollment

OTHER

Sponsor class

Stopped Difficulty recruiting.

Conditions

Sezary Syndrome
Pruritus

Interventions

DRUG: Aprepitant
DRUG: Placebo

Sponsor

Vanderbilt University Medical Center